Skip to main navigation Skip to search Skip to main content

ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases.

Priya Kumthekar, Shou-Ching Tang, Andrew J Brenner, Santosh Kesari, David E Piccioni, Carey K Anders, Jose A Carrillo, Pavani Chalasani, Peter Kabos, Shannon L Puhalla, Katherine H R Tkaczuk, Agustin Garcia, Manmeet S Ahluwalia, Jeffrey S Wefel, Nehal Lakhani, Nuhad K Ibrahim

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalClinical Cancer Research
Volume26
DOIs
StatePublished - Jun 15 2020

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this